Midterm results of directional atherectomy for treatment of atherosclerotic common femoral artery lesions

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00012497

Enrollment

286

Registered

2017-05-31

Start date

2017-04-27

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I70.2

Interventions

Group 1: Retrospective Evaluation of the safety and efficacy of directional atherectomy for atherosclerotic common femoral artery (CFA) lesions.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were treated with atherectomy in the common femoral artery in January 2009-January 2017 and fulfilled the following criteria: Clinical relevant claudication according to Rutherford-Becker classification in the stadium 2 to 5 or to the Fontaine classification in the stadium of IIa to V. Angiography: Arteriosclerotic stenosis (> 70% diameter reduction) or obstruction of the common femoral artery

Exclusion criteria

Exclusion criteria: no atherectomy in the common femoral artery

Design outcomes

Primary

Measure	Time frame
Efficacy: the incidence of target lesion revascularization.	—

Secondary

Measure	Time frame
Periinterventional complications, time to target lesion revascularization, primary and secondary patency of the target lesion, major or minor amputation of the target limb, limb salvage rates, change in Rutherford-Becker class, serious cardiovascular events (myocardial infarction, stroke, death)	—

Countries

Germany

Contacts

Public ContactAljoscha Rastan

Universitäts-Herzzentrum Freiburg-Bad Krozingen Kardiologie und Angiologie II

Aljoscha.Rastan@universitaets-herzzentrum.de076634020

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026